VRDN compared with CLDX: revenue, margins and what each company keeps, and the suppliers and customers both name

VRDNViridian Therapeutics, Inc.

Mkt capRevenueRevenue

CLDXCelldex Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

VRDNViridian Therapeutics, Inc.

CLDXCelldex Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VRDN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±17.2%▲+6.83%×0.40

May 5 '26±9.5%▲+33.36%×3.52

Q1 FY26±24.8%▲+1.90%×0.08

Nov 5 '25±18.1%▲+8.29%×0.46

CLDX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.8%▲+0.36%×0.04

May 8 '26±7.6%▲+1.95%×0.25

= impliedVRDN realized, solidCLDX realized, hatchedOne scale, both sides: full bar = 34%× = |realized| ÷ impliedSource: market data

Q1 FY26

±13.6%

▼−0.58%

×0.04

Q3 FY25±17.3%▲+7.50%×0.43

VRDNViridian Therapeutics, Inc.

25.29▲+2.49%· post 25.29

Mkt cap$2.8BRevenue$284,000Q2 FY26Revenue$71MFY25

CLDXCelldex Therapeutics, Inc.

29.04▼−3.52%· post 29.04

ClosedNov 2 '26

Mkt cap$2.3BRevenue$22,000Q2 FY26Revenue$7MFY24

Compare

ClosedNov 2 '26

VRDNViridian Therapeutics, Inc.

CLDXCelldex Therapeutics, Inc.

25.29▲+2.49%post 25.29

Price

29.04▼−3.52%post 29.04

$2.8B

Mkt cap

$2.3B

Q2 FY26$284,000

Revenue

$22,000Q2 FY26

FY25$71M

Revenue

$7MFY24

VRDN25.29▲+2.49%vsCLDX29.04▼−3.52%ClosedNov 2 '26